Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Bonds | 102.940 | 116.580 | 13.640 |
Convertible | 1.080 | 1.080 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 20.269 | 17.399 |
Price to Book | 3.702 | 1.990 |
Price to Sales | 2.304 | 2.263 |
Price to Cash Flow | 13.586 | 118.297 |
Dividend Yield | 1.643 | 4.216 |
5 Years Earnings Growth | 11.724 | 10.560 |
Name | Net % | Category Average |
---|---|---|
Corporate | 62.860 | 34.193 |
Government | 34.635 | 46.212 |
Cash | -6.163 | 12.156 |
Derivative | 3.668 | 12.572 |
Number of long holdings: 413
Number of short holdings: 6
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Italy 4.45 01- Sep-2043 | IT0005530032 | 3.64 | 106.500 | +0.04% | |
European Investment Bank 2.25 15-Mar-2030 | XS2535352962 | 3.27 | 98.830 | -0.06% | |
Spain 0 31-May-2025 | ES0000012K38 | 1.39 | 98.534 | +0.01% | |
France (Republic Of) | FR001400OHF4 | 1.35 | - | - | |
Kreditanstalt Fur Wiederaufbau | DE000A30VUK5 | 1.31 | - | - | |
Eur C Usd P @1.130000 Eo | - | 1.22 | - | - | |
Kreditanstalt Fur Wiederaufbau | DE000A30VUG3 | 1.16 | - | - | |
Netherlands 0 15-Jul-2031 | NL00150006U0 | 1.09 | 85.820 | +0.55% | |
Spain .85 30-Jul-2037 | ES0000012I24 | 1.07 | 75.480 | +0.52% | |
Eur C Usd P @1.130000 Eo | - | 0.92 | - | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Eurizon Tesoreria Euro AM | 1.63B | 2.84 | 1.54 | 0.32 | ||
Eurizon Obbligazioni Euro Breve Tea | 719.85M | 2.16 | 0.47 | 0.28 | ||
Eurizon Obbligazioni Euro Breve Ted | 719.85M | 0.92 | 0.06 | 0.16 | ||
Eurizon Riserva 2 anni A | 431.58M | 2.06 | -0.63 | - | ||
Eurizon Riserva 2 anni B | 431.58M | 2.22 | -0.44 | - |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review